• Eczema
  • COPD Move
  • CRD Closing banner
  • Banner Child

    Putting you at the centre of all decisions affecting your health

  • Banner map

    30% of the European population lives with allergies, asthma and COPD

  • Banner hands

    Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

Patients participate at severe asthma course in Palermo
Severe asthma is a difficult to control condition that affects people’s health and daily life and puts them at frequent risk of hospitalisation. The treatment for severe asthma absorbs many resources  ...

Read more

PRESS RELEASE: Launch of a political call to action on allergy and asthma in Europe
EAACI, EFA and the European Parliament Interest Group on allergy and asthma launch a political call to action in Europe April 25th 2017, Brussels: Today, healthcare professionals, patients and polic ...

Read more

Swiss new learning air quality platform for pupils of aged 13 to 16
French and German speaking Swiss pupils, can now explore the air they breathe though an online platform put developed by Swiss federal office of environment. EFA Member the Swiss LungenUnion has colla ...

Read more

myAirCoach will be featured at CeBIT
myAirCoach consortium will meet in Brussels for the second year technical review with the European Commission that will be held on the 7th of March. The meeting represents an opportunity to assess t ...

Read more

FENAER participates at the Spanish Respiratory Society Congress
EFA Spanish Member FENAER brought the perspective of respiratory patients to the SEPAR Pacientes meeting. Mª Emilia Carretero, FENAER Board Member highlighted that patient participation should be embe ...

Read more

The first EP event of the year put the focus on health: Act. Believe. Care.
Chronic respiratory diseases need public policy solutions at European level to respond to increasing disease prevalence, unmet treatment needs, high cost of hospitalisations, work and school sick-leav ...

Read more

MyAirCoach will be tested in 2017
In November 2016, we met in Manchester with our partners of the Horizon 2020 project myAirCoach to track the status quo in all work-packages, the main results achieved in 2016 and to plan the third an ...

Read more

Third year of scent sensitivity campaign in Finland
EFA Member the Finnish Allergy and Asthma Federation organized its scent sensitivity campaign for the third time last November attracting media attention and visibility to the problem of fragrances.  ...

Read more

First congress of allergy respiratory patients in Spain
On the occasion of World COPD Day EFA Spanish Member FENAER, organized the First Congress of Allergy and Respiratory Patients in Madrid. During the event, FENAER presented the outcome of their latest  ...

Read more

New asthma app launched in Latvia
PulmoGPS in collaboration with Wrong Digital and Faculty of Medicine of University of Latvia have developed an inhaler reminder application for asthmatics uzelpo.lv and breatheit.eu. Our member the La ...

Read more

PRESS RELEASE: Smartphones could improve young people’s health literacy and adherence
2016 European Health Forum Gastein (Austria) – Asthma is the most common chronic disease in childhood. Today, 30 million European children and adults below the age of 45 years old have asthma and 15,0 ...

Read more

EFA’s research on asthma in adolescence will be presented in Gastein
Our latest survey on adherence to treatment of young patients with asthma will be presented at the European Health Forum Gastein (EHFG), the most influential EU health policy conference that will take ...

Read more

Vote for myAirCoach to win the EC Innovation Radar Prize
The European Commission has listed the myAirCoach device as one of the high potential innovations in EU-funded research and innovation projects for the Innovation Radar Prize 2016. myAirCoach partne ...

Read more

New treatment to reduce asthma severity – Promising AirPROM study
The University of Leicester has led a ground-breaking study, funded by Novartis Pharmaceuticals, National Institute for Health Research (NIHR) and EU-funded project AirPROM, on a new drug that may in  ...

Read more

AirPROM legacy – Check out the booklet
The AirPROM project ended in May 2016, with a public event organised by EFA at the European Parliament, hosted by MEP David Borrelli. However the work does not finish when a project ends, especially w ...

Read more

U-BIOPRED's role on patient involvement
The Innovative Medicines Initiative (IMI) has published an interview with Professor Peter Sterk, coordinator of U-BIOPRED, one of the first projects launched by the IMI in 2009. According to Sterk,  ...

Read more

Chronic diseases in Europe: the Commission is urged to act
EFA, the European Chronic Diseases Alliance (ECDA) and other public health organisations have sent an open letter to the European Commission urging them to act on chronic diseases. Chronic diseases  ...

Read more

European Medicines Agency celebrates 10 years of collaboration with patients
Our continuous input into the information, evaluation and safety and development policies of medicines in Europe is an achievement that we celebrate, especially after the renewal of EFA membership to  ...

Read more

EFA President moderates debate on care and research at EAACI Congress
On the 13th of June, EFA President Mikaela Odemyr co-moderated a debate at a high-level policy meeting on the challenges and opportunities the European Union has to address allergy and asthma. This me ...

Read more

European Parliament fights illicit trade of tobacco products
In the EU, tobacco continues to be the most significant cause of premature deaths responsible for nearly 700,000 deaths every year. One week after the World No Tobacco Day, the European Parliament rat ...

Read more